Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Abbott LaboratoriesNovartisEli Lilly andAbbViePfizer
SymbolNYSE:ABTNYSE:NVSNYSE:LLYNYSE:ABBVNYSE:PFE
Price Information
Current Price$124.35$88.02$189.25$107.91$38.57
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score2.42.02.12.82.3
Analysis Score2.43.22.41.42.1
Community Score2.82.32.82.92.9
Dividend Score3.32.52.55.03.3
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score1.91.91.33.11.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$124.06$108.50$196.40$115.75$38.57
% Upside from Price Target-0.23% downside23.27% upside3.78% upside7.27% upside0.00% upside
Trade Information
Market Cap$220.29 billion$201.45 billion$181.49 billion$190.44 billion$215.13 billion
Beta0.830.590.370.840.7
Average Volume5,157,6861,980,3974,223,9557,433,25232,094,174
Sales & Book Value
Annual Revenue$31.90 billion$47.50 billion$22.32 billion$33.27 billion$51.75 billion
Price / Sales6.904.248.135.724.16
Cashflow$5.57 per share$7.45 per share$7.23 per share$10.09 per share$4.30 per share
Price / Cash22.3111.8226.1910.708.97
Book Value$17.70 per share$24.53 per share$2.81 per share($5.53) per share$11.46 per share
Price / Book7.033.5967.35-19.513.37
Profitability
Net Income$3.69 billion$11.73 billion$8.32 billion$7.88 billion$16.27 billion
EPS$3.24$5.24$6.04$8.94$2.95
Trailing P/E Ratio65.7928.4930.9222.8124.88
Forward P/E Ratio28.3913.5023.728.8712.60
P/E Growth2.061.761.571.542.79
Net Margins10.50%14.71%24.01%18.16%17.85%
Return on Equity (ROE)18.19%24.39%166.45%439.24%24.88%
Return on Assets (ROA)8.29%10.59%15.18%13.22%9.32%
Dividend
Annual Payout$1.80$2.08$3.40$5.20$1.56
Dividend Yield1.45%2.36%1.80%4.82%4.04%
Three-Year Dividend Growth35.85%13.60%42.31%84.37%-10.94%
Payout Ratio55.56%39.69%56.29%58.17%52.88%
Years of Consecutive Dividend Growth49 Years1 Years1 Years49 Years1 Years
Debt
Debt-to-Equity Ratio0.58%0.49%3.27%5.38%0.76%
Current Ratio1.70%0.91%1.36%0.95%1.40%
Quick Ratio1.19%0.69%1.06%0.81%1.13%
Ownership Information
Institutional Ownership Percentage72.58%9.86%75.59%67.49%67.36%
Insider Ownership Percentage1.70%0.01%0.09%0.09%0.08%
Miscellaneous
Employees109,000105,79435,00047,00088,300
Shares Outstanding1.77 billion2.29 billion958.99 million1.76 billion5.58 billion
Next Earnings Date4/20/2021 (Confirmed)4/27/2021 (Confirmed)4/27/2021 (Confirmed)4/30/2021 (Confirmed)5/4/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Pfizer rollout begins at WUSM campus following pause in J&J distribution - Student LifePfizer rollout begins at WUSM campus following pause in J&J distribution - Student Life
studlife.com - April 18 at 11:46 PM
Japanese leader asks Pfizer for additional vaccine supply - The ColumbianJapanese leader asks Pfizer for additional vaccine supply - The Columbian
columbian.com - April 18 at 11:46 PM
 Asian shares mixed amid cautious outlook for global economy Asian shares mixed amid cautious outlook for global economy
marketbeat.com - April 18 at 9:58 PM
Pfizer walk-up clinics open Monday and Tuesday at public health building - Port City DailyPfizer walk-up clinics open Monday and Tuesday at public health building - Port City Daily
portcitydaily.com - April 18 at 6:45 PM
South African variant may break through Pfizer vaccine protection, but vaccine highly effective, Israeli study says - ReutersSouth African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says - Reuters
reuters.com - April 18 at 6:45 PM
Japanese leader asks Pfizer for additional vaccine supply - ABC NewsJapanese leader asks Pfizer for additional vaccine supply - ABC News
abcnews.go.com - April 18 at 6:45 PM
UPDATE 2-South African variant may break through Pfizer vaccine protection, but vaccine highly effective, Israeli study saysUPDATE 2-South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
finance.yahoo.com - April 18 at 6:45 PM
South African variant may ‘break through’ Pfizer vaccine protection, but vaccine highly effective, Israeli study saysSouth African variant may ‘break through’ Pfizer vaccine protection, but vaccine highly effective, Israeli study says
financialpost.com - April 18 at 4:32 PM
Why Pfizer Shares Keep Moving Higher? - Yahoo FinanceWhy Pfizer Shares Keep Moving Higher? - Yahoo Finance
finance.yahoo.com - April 18 at 1:45 PM
Florida Vaccine Updates: Pfizer First Doses Return to FEMA Sites, Broward Department of Health Sites Not Requiring Appointments - NBC 6 South FloridaFlorida Vaccine Updates: Pfizer First Doses Return to FEMA Sites, Broward Department of Health Sites Not Requiring Appointments - NBC 6 South Florida
nbcmiami.com - April 18 at 1:45 PM
Pfizer vaccines now available without appointment at Mercedes-Benz Stadium - Atlanta Journal ConstitutionPfizer vaccines now available without appointment at Mercedes-Benz Stadium - Atlanta Journal Constitution
ajc.com - April 18 at 1:45 PM
FEMA mass vaccination sites to offer first doses of Pfizer again this week - WKMG News 6 & ClickOrlandoFEMA mass vaccination sites to offer first doses of Pfizer again this week - WKMG News 6 & ClickOrlando
clickorlando.com - April 18 at 1:45 PM
Virus is persistent: All youth 16 and up eligible for Pfizers COVID-19 vaccine on Monday - Ontario Argus Observer'Virus is persistent': All youth 16 and up eligible for Pfizer's COVID-19 vaccine on Monday - Ontario Argus Observer
argusobserver.com - April 18 at 1:45 PM
Japanese leader asks Pfizer for additional vaccine supply - ConchoValleyHomepage.comJapanese leader asks Pfizer for additional vaccine supply - ConchoValleyHomepage.com
conchovalleyhomepage.com - April 18 at 1:45 PM
Bethel AME hosts Pfizer vaccine clinic, sees low turnout - WTXL ABC 27Bethel AME hosts Pfizer vaccine clinic, sees low turnout - WTXL ABC 27
wtxl.com - April 18 at 8:44 AM
Should You Buy Pfizer in April? - Motley FoolShould You Buy Pfizer in April? - Motley Fool
fool.com - April 18 at 8:44 AM
13-year-old in Pfizer Covid vaccine trial who wants to be an epidemiologist: I like to learn everything I can - CNBC13-year-old in Pfizer Covid vaccine trial who wants to be an epidemiologist: 'I like to learn everything I can' - CNBC
cnbc.com - April 18 at 8:44 AM
Pfizer agreed to supply additional COVID-19 vaccines, says Japans vaccine minister - WHBL NewsPfizer agreed to supply additional COVID-19 vaccines, says Japan's vaccine minister - WHBL News
whbl.com - April 18 at 8:44 AM
Should You Buy Pfizer in April?Should You Buy Pfizer in April?
finance.yahoo.com - April 18 at 8:44 AM
These 2 Startups Are Searching for Cancer’s Hidden Weaknesses. What to Know.These 2 Startups Are Searching for Cancer’s Hidden Weaknesses. What to Know.
finance.yahoo.com - April 18 at 8:44 AM
The week that was: IT stocks mixed, Pfizer surges; Bandhan Bank plummetsThe week that was: IT stocks mixed, Pfizer surges; Bandhan Bank plummets
economictimes.indiatimes.com - April 18 at 3:59 AM
Pfizer pediatric vaccine trial to begin this summer in Kentucky - WSAZ-TVPfizer pediatric vaccine trial to begin this summer in Kentucky - WSAZ-TV
wsaz.com - April 18 at 12:19 AM
Why are some people experiencing side effects after their second Pfizer and Moderna shot? UCSF doctor explains - WLS-TVWhy are some people experiencing side effects after their second Pfizer and Moderna shot? UCSF doctor explains - WLS-TV
abc7chicago.com - April 18 at 12:19 AM
Pfizer agreed to supply additional COVID-19 vaccines, says Japans vaccine ministerPfizer agreed to supply additional COVID-19 vaccines, says Japan's vaccine minister
finance.yahoo.com - April 18 at 12:19 AM
Why are some people experiencing side effects after their second Pfizer and Moderna shot? UCSF doctor explains - KGO-TVWhy are some people experiencing side effects after their second Pfizer and Moderna shot? UCSF doctor explains - KGO-TV
abc7news.com - April 17 at 7:19 PM
Japanese PM, Pfizer CEO discuss delivery of additional vaccine doses in 2021 to Japan - WHBL NewsJapanese PM, Pfizer CEO discuss delivery of additional vaccine doses in 2021 to Japan - WHBL News
whbl.com - April 17 at 7:19 PM
The Latest: Ukraine gets 117,000 Pfizer doses via COVAX The Latest: Ukraine gets 117,000 Pfizer doses via COVAX
marketbeat.com - April 16 at 8:00 AM
China ramps up vaccination drive with free eggs, other goodsChina ramps up vaccination drive with free eggs, other goods
marketbeat.com - April 16 at 12:14 AM
EU Commission chief announces negotiations for extension of COVID-19 vaccine contract with Pfizer stretching to 2023EU Commission chief announces negotiations for extension of COVID-19 vaccine contract with Pfizer stretching to 2023
marketbeat.com - April 14 at 7:53 AM
EU to negotiate major vaccine contract extension with PfizerEU to negotiate major vaccine contract extension with Pfizer
marketbeat.com - April 14 at 7:53 AM
The Latest: Several states suspend J&J vaccine during probeThe Latest: Several states suspend J&J vaccine during probe
marketbeat.com - April 13 at 2:59 PM
The Latest: Johnson & Johnson delays shot rollout in Europe The Latest: Johnson & Johnson delays shot rollout in Europe
marketbeat.com - April 13 at 11:33 AM
Tweaked COVID vaccines in testing aim to fend off variantsTweaked COVID vaccines in testing aim to fend off variants
marketbeat.com - April 12 at 12:29 PM
The Latest: Vaccine shortages hitting poor countries The Latest: Vaccine shortages hitting poor countries
marketbeat.com - April 10 at 2:13 PM
The Latest: Pfizer asks US to allow more kids to get vaccineThe Latest: Pfizer asks US to allow more kids to get vaccine
marketbeat.com - April 9 at 5:03 PM
Australia to buy extra 20 million doses of Pfizer vaccineAustralia to buy extra 20 million doses of Pfizer vaccine
marketbeat.com - April 9 at 12:57 AM
Australia halts AstraZeneca vaccine for most people under 50Australia halts AstraZeneca vaccine for most people under 50
marketbeat.com - April 8 at 7:28 AM
Pfizer (NYSE:PFE) Now Covered by Analysts at Royal Bank of CanadaPfizer (NYSE:PFE) Now Covered by Analysts at Royal Bank of Canada
marketbeat.com - April 7 at 8:44 AM
The Latest: Arizona AG says governor cant block mask rulesThe Latest: Arizona AG says governor can't block mask rules
marketbeat.com - April 6 at 9:45 PM
The Latest: Wife of Montana governor also tests positiveThe Latest: Wife of Montana governor also tests positive
marketbeat.com - April 6 at 7:19 PM
The Latest: Tennessee governor opposes vaccine passportsThe Latest: Tennessee governor opposes vaccine passports
marketbeat.com - April 6 at 6:14 PM
The Latest: Chile delays several elections amid virus surgeThe Latest: Chile delays several elections amid virus surge
marketbeat.com - April 6 at 5:04 PM
The Latest: California aims to reopen more widely in JuneThe Latest: California aims to reopen more widely in June
marketbeat.com - April 6 at 3:45 PM
The Latest: Turkeys daily virus cases reach nearly 50,000The Latest: Turkey's daily virus cases reach nearly 50,000
marketbeat.com - April 6 at 3:29 PM
The Latest: WH: No credential to show if vaccinatedThe Latest: WH: No credential to show if vaccinated
marketbeat.com - April 6 at 2:57 PM
The Latest: WH: 28M vaccines doses to states this weekThe Latest: WH: 28M vaccines doses to states this week
marketbeat.com - April 6 at 1:39 PM
The Latest: WH: 28M vaccine doses to states this weekThe Latest: WH: 28M vaccine doses to states this week
marketbeat.com - April 6 at 1:38 PM
The Latest: Study: Moderna vaccine lasts at least 6 monthsThe Latest: Study: Moderna vaccine lasts at least 6 months
marketbeat.com - April 6 at 12:31 PM
Young professionals cut ahead of older Italians for vaccineYoung professionals cut ahead of older Italians for vaccine
marketbeat.com - April 3 at 2:35 AM
Dutch temporarily halt AstraZeneca shots for under-60s Dutch temporarily halt AstraZeneca shots for under-60s
marketbeat.com - April 2 at 11:47 AM
DateCompanyBrokerageAction
4/15/2021Abbott LaboratoriesAtlantic SecuritiesInitiated Coverage
3/17/2021Abbott LaboratoriesRaymond JamesBoost Price Target
1/28/2021Abbott LaboratoriesWells Fargo & CompanyBoost Price Target
1/28/2021Abbott LaboratoriesCowenBoost Price Target
1/28/2021Abbott LaboratoriesCredit Suisse GroupBoost Price Target
1/28/2021Abbott LaboratoriesMorgan StanleyBoost Price Target
1/28/2021Abbott LaboratoriesSVB LeerinkBoost Price Target
1/28/2021Abbott LaboratoriesBTIG ResearchUpgrade
10/22/2020Abbott LaboratoriesJefferies Financial GroupBoost Price Target
10/9/2020Abbott LaboratoriesJPMorgan Chase & Co.Boost Price Target
9/11/2020Abbott LaboratoriesWolfe ResearchInitiated Coverage
9/2/2020Abbott LaboratoriesThe Goldman Sachs GroupSet Price Target
8/28/2020Abbott LaboratoriesCitigroupBoost Price Target
3/23/2021NovartisSociete GeneraleReiterated Rating
3/22/2021NovartisSanford C. BernsteinInitiated Coverage
3/16/2021NovartisArgusReiterated Rating
1/22/2021NovartisBarclaysReiterated Rating
1/15/2021NovartisDeutsche Bank AktiengesellschaftInitiated Coverage
11/25/2020NovartisUBS GroupReiterated Rating
9/29/2020NovartisBerenberg BankInitiated Coverage
9/23/2020NovartisOddo BhfDowngrade
3/22/2021Eli Lilly andTruist SecuritiesBoost Price Target
2/1/2021Eli Lilly andMizuhoBoost Price Target
1/22/2021Eli Lilly andBank of AmericaBoost Price Target
6/16/2020Eli Lilly andGuggenheimUpgrade
4/7/2021AbbVieRoyal Bank of CanadaInitiated Coverage
11/18/2020AbbVieBMO Capital MarketsInitiated Coverage
2/3/2021PfizerDZ BankReiterated Rating
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.